Clinical Trials Update: Mar. 28, 2003
Leukemia Cancer/Chemotherapy Pancreatic Cancer
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
A clinical trial to study an investigational, personalized immunotherapeutic drug plus Gleevec in patients with chronic myelogenous leukemia (CML). Volunteers who are at least 18 years old, and have a Philadelphia chromosome positive chronic myelogenous leukemia in first chronic phase, may be eligible. Research sites located throughout the world.
A study of educational material for people newly diagnosed with cancer. Volunteers who are over the age of 18 and have had an initial diagnosis of cancer within the past year may be eligible. Research sites located throughout the United States.
A phase 2 research study of an investigational medication in patients with locally advanced or metastatic pancreatic cancer. Volunteers with adenocarcinoma of the pancreas, who have had no prior therapy, may be eligible. Research sites located throughout the world.
Copyright 2003 CenterWatch. All rights reserved.